Cannabis Use Associated With Improved Outcomes In Bipolar Patients

Comedy_and_tragedy_masks_without_background.svg

MASSACHUSETTS: Cannabis use is associated with an alleviation of clinical symptoms in patients with bipolar disorder, and does not negatively impact cognitive performance, according to clinical trial data published in the journal PLoS One. Investigators with Harvard Medical School, Tufts University, and McLean Hospital in Massachusetts assessed the impact of marijuana use on mood symptomology and cognitive Read the full article…

Thousands Of Peer-Reviewed Studies Specific To Medical Cannabis Have Been Published Over Past Decade

Medical-Science

ISRAEL: The total number of peer-reviewed scientific papers dedicated to cannabis, and the therapeutic use of cannabis in particular, has increased exponentially in recent years, according to data published the journal Population Health Management. Israeli researchers assessed trends in the number of scientific publications specific to cannabis as compared to all scientific publications during the years 2000 to 2017. They reported: Read the full article…

Study: Marijuana Use Associated With Lower Diabetes Risk

Marijuana Use Associated With Lower Diabetes Risk

CANADA: The past use of cannabis is significantly associated with lower odds of diabetes in adults, according to data published in the journal Drug and Alcohol Review. Investigators with the University of Toronto assessed the association between cannabis use and diabetes in a nationally representative sample, while accounting for a range of potential confounders – including lifestyle behaviors, socio-demographics, Read the full article…

Ohio Medical Marijuana Advisory Committee November 2019 Meeting Notice

Ohio Medical Marijuana Control Program

OHIO: THE OMMCP has announced that its Medical Marijuana Advisory Committee will hold a meeting on November 8, 2018, beginning at 10:00 a.m. Please note there will be an additional afternoon session beginning at 1:00 p.m. Click here for a copy of the meeting notice.

War Veteran Non-Profit Hosts Inaugural Medical Cannabis Conference Days Before Missourians Vote on Medical Cannabis Ballot

St. LOUIS

Nation’s Cannabis Experts Address Consumers, Healthcare Providers & Emerging Trade at October 27 & 28 St. Charles-based Forum MISSOURI: The inaugural Missouri Medical Cannabis Conference will be held Saturday & Sunday, October 27 and October 28, and will provide voters, potential patients, caretakers, varied healthcare providers and those interested in the associated business and trade of Read the full article…

Cannabics Pharmaceuticals Announces Positive Results for Pilot Study on Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)

MMJ reduces opioid use

Preliminary findings showed +80% of patients had increase in appetite and 60% +10% weight increase ISRAEL & MARYLAND: Cannabics Pharmaceuticals, a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced the results of its pilot study to test the efficacy of Cannabics capsules for the treatment of cancer anorexia-cachexia syndrome (CACS) in advanced Read the full article…

Study: Adjunctive Cannabis Use Improves Treatment Retention In Opioid-Dependent Subjects

Opioid-Addiction

MISSOURI: The intermittent use of cannabis can play a positive role in opioid-dependent subjects undergoing treatment, according to a review published in the journal Cannabis and Cannabinoid Research. Researchers from the Washington University School of Medicine in St. Louis assessed data evaluating the relationship between the use of cannabis and opioids. They reported, “Adjunct cannabis use alongside current treatment Read the full article…

Yom Chai Forms Strategic Partnership With Israeli Research and Development Company Kaneh-B

research

Partnership Will Conduct Scientific Clinical Trials On ADHD; Distribute Approved European Dermal Products ISRAEL:  Yom Chai has entered into a strategic partnership with Kaneh-B to co-found the development and clinical validation of a range of cannabis based ADHD products. Yom Chai’s objective is to conduct scientific trials in Israel utilizing various Cannabinoid and Terpene profiles with the goal of Read the full article…

Father of THC Dr. Raphael Mechoulam Keynotes CannX Oct 14-16 In Tel Aviv

Dr Raphael Machoulam

ISRAEL: Dr. Raphael Mechoulam, Professor of Medicinal Chemistry at The Hebrew University of Jerusalem, Israel, and the man credited with first discovering and isolating THC will keynote the 3rd International Medical Cannabis Conference (CannX), October 14-16th in Tel Aviv. Speaking on The Plant Cannabinoids And The Endocannabinoid System — An Overview Of Research Over Five Decades, Dr. Mechoulam will set Read the full article…